Cargando…
Preliminary results of a triple peptide escalating dose vaccination phase I/II clinical trial as consolidation treatment in women affected by ovarian cancer
Autores principales: | Napoletano, Chiara, Visconti, Valeria, Antonilli, Morena, Zizzari, Ilaria G, Rahimi, Hassan, Battisti, Federico, Caponnetto, Salvatore, Barchiesi, Giacomo, Rughetti, Aurelia, Bellati, Filippo, Benedetti-Panici, Pierluigi, Nuti, Marianna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991372/ http://dx.doi.org/10.1186/2051-1426-1-S1-P227 |
Ejemplares similares
-
Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial
por: ANTONILLI, MORENA, et al.
Publicado: (2016) -
Bevacizumab-Based Chemotherapy Triggers Immunological Effects in Responding Multi-Treated Recurrent Ovarian Cancer Patients by Favoring the Recruitment of Effector T Cell Subsets
por: Napoletano, Chiara, et al.
Publicado: (2019) -
Immune Effects of Trastuzumab
por: Nuti, Marianna, et al.
Publicado: (2011) -
The Macrophage Galactose-Type C-Type Lectin (MGL) Modulates Regulatory T Cell Functions
por: Zizzari, Ilaria Grazia, et al.
Publicado: (2015) -
HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy
por: Zizzari, Ilaria Grazia, et al.
Publicado: (2011)